PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.78%
Negative revenue growth while 2127.T stands at 43.41%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-5.59%
Negative gross profit growth while 2127.T is at 68.84%. Joel Greenblatt would examine cost competitiveness or demand decline.
-26.75%
Negative EBIT growth while 2127.T is at 185.70%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-24.32%
Negative operating income growth while 2127.T is at 169.60%. Joel Greenblatt would press for urgent turnaround measures.
-22.82%
Negative net income growth while 2127.T stands at 230.25%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-22.81%
Negative EPS growth while 2127.T is at 230.29%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-22.81%
Negative diluted EPS growth while 2127.T is at 230.29%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.00%
Share reduction while 2127.T is at 0.01%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 2127.T is at 0.01%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
152.83%
10Y revenue/share CAGR at 50-75% of 2127.T's 259.74%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
51.72%
5Y revenue/share CAGR above 1.5x 2127.T's 11.10%. David Dodd would look for consistent product or market expansions fueling outperformance.
34.22%
Positive 3Y CAGR while 2127.T is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
137.62%
Net income/share CAGR at 75-90% of 2127.T's 179.44%. Bill Ackman would press for strategic moves to boost long-term earnings.
68.73%
Positive 5Y CAGR while 2127.T is negative. John Neff might view this as a strong mid-term relative advantage.
25.56%
Positive short-term CAGR while 2127.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
310.55%
10Y equity/share CAGR 1.25-1.5x 2127.T's 273.06%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
81.59%
5Y equity/share CAGR above 1.5x 2127.T's 31.38%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
35.06%
Positive short-term equity growth while 2127.T is negative. John Neff sees a strong advantage in near-term net worth buildup.
136.36%
10Y dividend/share CAGR above 1.5x 2127.T's 50.00%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
160.00%
Stable or rising mid-term dividends while 2127.T is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
62.50%
3Y dividend/share CAGR 1.25-1.5x 2127.T's 50.00%. Bruce Berkowitz checks if the company's short-term profits or payout policy justify these higher hikes.
3.80%
AR growth is negative/stable vs. 2127.T's 86.42%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
8.07%
Inventory growth of 8.07% while 2127.T is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
0.32%
Asset growth well under 50% of 2127.T's 7.98%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
2.65%
Under 50% of 2127.T's 6.83%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-4.27%
We’re deleveraging while 2127.T stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-0.81%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.